Flavours launches NutraBitz all-natural, probiotic soft chews
CORONA, Calif. Flavours Inc. on Monday announced the introduction of NutraBitz, a line of all-natural, oat-based soft chews containing both prebiotics and probiotics for private label applications.
“Probiotics are one of the hottest market trends today, but right now consumers can’t get them in delivery forms that make taking probiotics enjoyable. NutraBitz changes that,” Flavours Inc. director of sales, Tara Foster, said.
Flavours plans to showcase the new product offering Supply Side West, which is being held Oct. 22-24 in Las Vegas.
According to the company, the idea for NutraBitz was inspired by the continuing emergence of medical research demonstrating the benefits of probiotics in a wide variety of health conditions and growing consumer interest and demand for probiotic alternatives to refrigerated yogurts and probiotic capsules and tablets. “Consumers are now much more aware of the benefits of probiotics and are looking for other ways of getting them into the daily diet,” the company stated.
Each 5.5 gram NutraBitz soft chew is 15-20 calories and contains 1 billion CFU of the GanedenBC30 strain of Bacillus coagulans probiotics.
Sambucol releases cold/flu relief tablets; homeopathic remedy for common cold
NOTTINGHAM, England Healthcare Brands on Thursday announced the introduction of a new elderberry product shipping this fall called Sambucol Cold & Flu Relief Tablets. The new product is being billed as a homeopathic formulation of black elderberry and zinc gluconate and is safe for children four years and older, as well as adults, the company noted.
According to data from the U.S. Department of Agriculture, elderberries have twice the antioxidant capacity of blueberries and significantly more than the capacity of cranberries. Throughout history black elderberry has been used to treat colds, flu, fever, burns, cuts and more. Elderberries are rich in antioxidants, which are thought to be necessary to support the immune system.
Scientists warn diabetes patients may have increased bleeding from taking aspirin
LONDON Scientists from the University of Dundee have released a report that states taking aspirin may lead to increased internal bleeding and other complications in diabetes patients.
Many people take aspirin daily to help reduce the risk of heart attack. But, scientists have concluded that taking aspirin doesn’t mitigate the risk of heart attack for diabetes patients, unless they already had heart disease.
Following an eight-year study that followed 1,276 diabetes patients who took aspirin, a placebo or an antioxidant to help prevent heart disease, researchers concluded that aspirin should be taken only by patients already dealing with heart disease or who have suffered a stroke.